Search

everythinglearnresearchcommunity

for

Search:↓

Special cells can help regrow hair in alopecia areata.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Topical metformin gel is as effective and safe as steroids for treating alopecia areata.

Interleukin-15 can help hair growth and protect hair follicles.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Hair follicles prevent NK cell attacks to avoid hair loss.

ILC1-like cells can independently cause alopecia areata.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Gut bacteria differences could help diagnose and treat alopecia areata.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors show promise for treating various skin diseases.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.